Today in Health Affairs Forefront, Katie Keith discusses the proposed rule from HHS to significantly revise the agency’s prior interpretation of Section 1557 of the Affordable Care Act, which prohibits discrimination on the basis of race, color, national origin, sex, age, and disability in certain health programs and activities. Cynthia Ho and Liza Vertinsky discuss how getting a clearer picture of the true costs and risks of drug research and development is a critical starting point in ensuring a more balanced and accurate policy approach toward biomedical innovation. Health Affairs Forefront provides readers with the latest high value health policy news, commentary, and analysis. With your support we can continue to offer communitywide access to the industry-leading perspectives featured every day on our digital publication.
|